Free Access
Med Sci (Paris)
Volume 29, Mars 2013
Page(s) 19 - 24
Section M/S Revues
Published online 13 March 2013
  1. Lanternier F, Dannaoui E, Morizot G, et al. A global analysis of mucormycosis in France: the RetroZygo Study (2005–2007). Clin Infect Dis 2012 ; 54 (suppl 1) : S35–S43. [CrossRef] [PubMed] [Google Scholar]
  2. Petrikkos G, Skiada A, Lortholary O, et al. Epidemiology, clinical manifestations of mucormycosis. Clin Infect Dis 2012 ; 54 (suppl 1) : S23–S34. [CrossRef] [PubMed] [Google Scholar]
  3. Rammaert B, Lanternier F, Zahar JR, et al. Healthcare-associated mucormycosis. Clin Infect Dis 2012 ; 54 (suppl 1) : S44–S54. [CrossRef] [PubMed] [Google Scholar]
  4. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005 ; 41 : 634–653. [CrossRef] [PubMed] [Google Scholar]
  5. Ruping MJ, Heinz WJ, Kindo AJ, et al. Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother 2010 ; 65 : 296–302. [CrossRef] [PubMed] [Google Scholar]
  6. Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011 ; 17 : 1859–1867. [CrossRef] [PubMed] [Google Scholar]
  7. Skiada A, Lanternier F, Groll AH, et al. Diagnosis and treatment of mucormycosis in patients with haematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica 2012 ; 14 septembre (online). [PubMed] [Google Scholar]
  8. Bouchara JP, Oumeziane NA, Lissitzky JC, et al. Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components. Eur J Cell Biol 1996 ; 70 : 76–83. [PubMed] [Google Scholar]
  9. Chamilos G, Lewis RE, Lamaris G, et al. Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage. Antimicrob Agents Chemother 2008 ; 52 : 722–724. [CrossRef] [PubMed] [Google Scholar]
  10. Chamilos G, Lewis RE, Hu J, et al. Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc Natl Acad Sci USA 2008 ; 105 : 9367–9372. [CrossRef] [Google Scholar]
  11. Adam RD, Hunter G, DiTomasso J, Comerci G Jr. Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis 1994 ; 19 : 67–76. [CrossRef] [PubMed] [Google Scholar]
  12. Antoniadou A. Outbreaks of zygomycosis in hospitals. Clin Microbiol Infect 2009 ; 15 (suppl 5) : 55–59. [CrossRef] [PubMed] [Google Scholar]
  13. Thomson SR, Bade PG, Taams M, Chrystal V. Gastrointestinal mucormycosis. Br J Surg 1991 ; 78 : 952–954. [CrossRef] [PubMed] [Google Scholar]
  14. Tournas VH. Spoilage of vegetable crops by bacteria and fungi and related health hazards. Crit Rev Microbiol 2005 ; 31 : 33–44. [CrossRef] [PubMed] [Google Scholar]
  15. Cheng VC, Chan JF, Ngan AH, et al. Outbreak of intestinal infection due to Rhizopus microsporus. J Clin Microbiol 2009 ; 47 : 2834–2843. [CrossRef] [PubMed] [Google Scholar]
  16. Verma A, Brozman B, Petito CK. Isolated cerebral mucormycosis: report of a case and review of the literature. J Neurol Sci 2006 ; 240 : 65–69. [CrossRef] [PubMed] [Google Scholar]
  17. Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes 1982 ; 31 : 1109–1114. [CrossRef] [PubMed] [Google Scholar]
  18. Sun HY, Singh N. Mucormycosis: its contemporary face and management strategies. Lancet Infect Dis 2011 ; 11 : 301–311. [CrossRef] [PubMed] [Google Scholar]
  19. Xhaard A, Lanternier F, Porcher R, et al. Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003–2008). Clin Microbiol Infect 2012 ; 18 : E396–E400. [CrossRef] [PubMed] [Google Scholar]
  20. Chamilos G, Marom EM, Lewis RE, et al. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 2005 ; 41 : 60–66. [CrossRef] [PubMed] [Google Scholar]
  21. Bitar D, Van Cauteren D, Lanternier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis 2009 ; 15 : 1395–1401. [CrossRef] [PubMed] [Google Scholar]
  22. Phai Pang KA, Godet C, Fekkar A, et al. Breakthrough invasive mould infections in patients treated with caspofungin. J Infect 2012 ; 64 : 424–429. [CrossRef] [PubMed] [Google Scholar]
  23. Suzuki K, Sugawara Y, Sekine T, et al. Breakthrough disseminated zygomycosis induced massive gastrointestinal bleeding in a patient with acute myeloid leukemia receiving micafungin. J Infect Chemother 2009 ; 15 : 42–45. [CrossRef] [PubMed] [Google Scholar]
  24. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 1994 ; 39 : 3–22. [CrossRef] [PubMed] [Google Scholar]
  25. Rothstein RD, Simon GL. Subacute pulmonary mucormycosis. J Med Vet Mycol 1986 ; 24 : 391–394. [CrossRef] [PubMed] [Google Scholar]
  26. Marchiori E, Zanetti G, Meirelles GS, et al. The reversed halo sign on high-resolution CT in infectious and noninfectious pulmonary diseases. AJR Am J Roentgenol 2011 ; 197 : W69–W75. [CrossRef] [PubMed] [Google Scholar]
  27. Cooter RD, Lim IS, Ellis DH, Leitch IO. Burn wound zygomycosis caused by Apophysomyces elegans. J Clin Microbiol 1990 ; 28 : 2151–2153. [PubMed] [Google Scholar]
  28. Skiada A, Petrikkos G. Cutaneous zygomycosis. Clin Microbiol Infect 2009 ; 15 (suppl 5) : 41–45. [CrossRef] [Google Scholar]
  29. Singh N, Gayowski T, Singh J, Yu VL. Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis 1995 ; 20 : 617–620. [CrossRef] [PubMed] [Google Scholar]
  30. Mooney JE, Wanger A. Mucormycosis of the gastrointestinal tract in children: report of a case and review of the literature. Pediatr Infect Dis J 1993 ; 12 : 872–876. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.